The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drugAffordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
GlobalData on MSN2d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...
PrEP is a medication that helps prevent HIV infection, and its inclusion would be a significant ... among hijra/transgender people is 18 times and among people who use drugs is 43 times of the overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback